Israel’s Clearmind Medicine has been granted permission to begin trials at Sheba Medical Center of MEAI (5-methoxy-2-aminoindane) – a synthetic compound developed in Canada to treat alcoholics. Clearmind spent years making the MEAI-based oral capsules conform to medical standards.
https://nocamels.com/2023/05/biotech-firm-using-psychedelics-to-treat-alcohol-addiction/